Selective expression of murine cytomegalovirus (MCMV) immediate-early (IE) genes leads to the presentation by the major histocompatibility complex (MHC) class I molecule L a of a peptide derived from MCMV IE protein pp89 (Reddehase, M. J., J. B. Rothbard, and U. H. Koszinowski. 1989. Nature (Lond.). 337:651). Characterization of endogenous antigenic peptides identified the pp89 peptide as the nonapeptide msYPHFMFFNLt76 (del Val, M., H.-J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. . Cell. 66:1145. Subsequent expression of MCMV early genes prevents presentation of pp89 (del Val, M., K. Mfinch, M. J. Reddehase, and U. H. Koszinowski. 1989. Cell. 58:305). We report on the mechanism by which MCMV early genes interfere with antigen presentation. Expression of the IE promoter-driven bacterial gene lacZ by recombinant MCMV subjected antigen presentation of B-galactosidase to the same control and excluded antigen specificity. The La-dependent presence of naturally processed antigenic peptides also in nonpresenting cells located the inhibitory function subsequent to the step of antigen processing. The finding that during the E phase of MCMV gene expression the MHC class I heavy chain glycosylation remained in an Endo H-sensitive form suggested a block within the endoplasmic reticulum/c/s-Golgi compartment. The failure to present antigenic peptides was explained by a general retention of nascent assembled trimolecular MHC class I complexes. Accordingly, at later stages of infection a significant decrease of surface MHC class I expression was seen, whereas other membrane glycoproteins remained unaffected. Thus, MCMV E genes endow this virus with an effective immune evasion potential. These results also indicate that the formation of the trimolecular complex of MHC dass I heavy chain, ~2-microglobulin, and the finally trimmed peptide is completed before entering the medial-Golgi compartment.
T lymphocytes recognize short peptides derived from antigenic proteins. These peptides are presented at the cell surface by specialized molecules encoded in the MHC (reviewed in reference 1). There are two classes of MHC molecules that present peptides at the cell surface. MHC class II molecules present peptides that are derived from proteins degraded in endosomal vesicles to CD4 + T lymphocytes, whereas MHC class I molecules present peptides from proteins degraded in the cytosol to CD8 + T lymphocytes. For cytosolic antigen degradation a nonlysomal proteinase complex encoded in the MHC represents a candidate (2) (3) (4) . Although translocation of peptides into the rough endoplasmic reticulum (EIL) t is 1Abbreviations used in this paper: Act D, actinomycin D; B-gal, /3-galactosidase;/3zm,/32-microglobulin; CH, cycloheximide; ER, endoplasmic reticuhm; HCMV, human cytomegalovirus; IE, immediate-early; MCMV, murine cytomegalovirus; MEF, mouse embryo fibroblasts; p.i., postinfection.
believed to require ATP-dependent peptide transporters (5-7), recent evidence indicates that peptide translocation can occur independently of ATP (8) . x-ray crystallographic analysis of an MHC dass I protein has revealed a cleft where peptides are bound (9) . A block in the secretory pathway prevents antigen presentation (10, 11) . Indirect evidence points to the EtL or c/s-Golgi reticulumAalvage compartment as the place of peptide binding (12) (13) (14) , but subsequent compartments cannot be excluded. Studies on cell lines defective in antigen presentation suggest that only after assembly of the MHC class I heavy chain with the peptide and/32-microglobulin (/32m) is a stable trimolecular complex exported to the plasma membrane (15, 16) . MHC dass I molecules without peptide have a different conformation (14, 17, 18) and are deficient with respect to surface transport and stability (15, 19) .
CD8 + T lymphocytes that recognize peptides derived from viral proteins synthesized in infected cells play a deci-sive role in the antiviral defence. Yet, some viruses have found the means to interfere with immune recognition (listed in reference 20). Extensively studied is the interference strategy of adenoviruses. In the case of the tumorigenic adenovirus type 12, the viral protein E1A blocks MHC class I expression already at the level of transcription (21, 22) . In contrast, the E3/19K protein of adenovirus type 2 binds to the MHC class I molecule and, by retaining it in the ER/c/s-Golgi compartment, blocks cell surface expression and antigen presentation (23-26).
Cytomegaloviruses (CMV) are species-specific herpes viruses, which persist in the host for life after infection. Viral persistency can take the form of chronic disease, asymptomatic productive infection, or even viral latency. MHC class I-restricted T lymphocytes play a prominent protective role (reviewed in reference 27). Accordingly, infection of the immature or immunocompromised host can result in severe CMV disease and death. Thus, CMV often causes disease after bone marrow transplantation and represents the major viral problem during the final stages of AIDS, In permissively infected cells, CMV gene expression is regulated in a cascade fashion characteristic for herpes viruses. Viral proteins encoded by genes expressed in the immediate-early (IE) phase of infection control the activation of early (E) phase genes. E proteins are required for viral DNA synthesis, which is followed by the synthesis of structural proteins during the late phase of infection. Studies on murine CMV (MCMV) have revealed that CMV also has the capacity to interfere with antigen presentation (28). Recognition by CTL of the IE protein pp89, a nonapeptide of which is presented by the MHC class I molecule L d in the BALB/c strain of mice (29-31), is abolished after expression of E genes (28). The failure of pp89 presentation appeared to be selective in that MCMV E antigens could be presented. Since pp89 synthesis, stability, and nuclear transport remained unchanged in the E phase, we hypothesized that characteristics of the protein or its regulatory function affected pp89 processing during the E phase.
Here we define the step at which MCMV E gene products interfere with the natural pathway of pp89 processing and peptide presentation. First, the inhibition of further glycosylation indicates that the transport of MHC class I molecules through the Golgi compartment is generally inhibited by MCMV E gene functions. Second, because cells with arrested transport of MHC class I molecules contain already the correctly processed nonapeptide of pp89, these results suggest the ER/cis-Golgi compartment represents the site of antigenic peptide binding to MHC class I molecules.
Materials and Methods
Mice. BALB/cJ (H-2 d) and BALB/cJ-H-2 din2 (H-2 dm2) mice were bred in our own colony under spedfic pathogen-free conditions.
Cells. Mouse embryo fibroblasts (MEF) prepared from either strain of mice, were used after three in vitro passages for virus infection and extraction of naturally processed peptides. In some experiments the SV40-transformed MEF cell line, BALB.SV, was used (31) . The cell line P13.1 originates from the mastocytoma P815 cells that were transfected with the lacZ gene encoding ~-gal (32) .
Viruses. MCMV of the strain Smith (VR-194; American Type Culture Collection [ATCC], RockviUe, MD) was employed as tissue culture-grown virus. The MCMV recombinant MCMV lacl was constructed essentially as described for RM408 (33) , but using DNA of the wild-type strain Smith. The recombinant vaccinia viruses MCMV-iel-VAC, expressing pp89, and vSC8, expressing B-gal, have been described before (34, 35) .
Antibodies. The following mAbs were used: 28-14-8s (antiLdoL3, reactive with aLl L a molecules) (18); 64-3-7 (anti-Ldc~2, specific for unassembled L a) (18); 34-5-8s (anti-D a) (HB 102; ATCC); K17 217.1.3 (anti-murine transferrin receptor) (TIB 219; ATCC); IM7-8.1E4 (anti-pgpl) (36) .
Infection Conditions. Selective expression of MCMV IE gene products was achieved by infection of cells with MCMV in the presence of cycloheximide (CH), which was replaced 3 h later by actinomycin D (Act D). Controlled transition to the E phase was achieved by incubating the ceils in the absence of drugs for varied periods of time after removal of CH; IE proteins translated in this period activate the transcription of E genes, until Act D blocks further transcription (see Fig. 2 A) . Infection was performed by centrifugation at 800 g for 30 rain, to enhance the efficiency by a factor of 10-40.
Isolation of Endogenously Processed Peptides. Processed peptides
were extracted with TFA from whole cells (,~10 s cells per extraction) and tested in a CTL assay as described (31) . The protocol for peptide extraction from infected cells mimicked the preparation of target calls. Cells were trypsinized at 7 h postinfection (p.i.), incubated in suspension for 90 rain at 37~ and then subjected to acid extraction.
Cytolytic Assays. For the production of target ceils, cells were labeled with 51Cr for 90 min. Incubation of labeled P815 cells for 1 h at 37~ with HPI.C fractions to be tested for the presence of biologically active naturaLly processed peptides preceded the addition of polyclonal pp89-specific CTL (31) . La-restricted and B-gal-specific CTL were generated by in vitro restimulation of spleen cells from mice in vivo primed with vSC8 (107 cells/ml in culture medium) with 30 Gy-irradiated P13.1 cells (10 s ceUs/ml in culture medium), CTL were propagated by weekly restimulations and addition of recombinant human Ib2 (100 U/ml). Graded numbers of effector cells in threefold dilution steps were used in a standard 3-h cytolytic assay. Data represent the mean percentage of specific lysis from three replicate cultures. The E/T ratio that gave plateau lysis with either CTL usually ranged from 50:1 to 5:1, and in some of the experiments only the values of plateau lysis are shown.
Metabolic Labeling and Immunoprecipitation. Cells were washed three times in methionine-free medium before incubation with [3SS]methionine (1, 200 Ci/mmol; Amersham, Braunschweig, Germany) at a concentration of 500 #Ci/ml at 37~ for the time indicated in the figure legends. In pulse-chase experiments, labeled ceils were washed in prewarmed complete medium with 10 mM nonlabeled methionine and incubated further for the indicated time. After washing with PBS, cells (2 x 106) were lysed in 1 ml lysis buffer (1% NP-40, 5 mM MgClz, 140 mM NaCI, 20 mM Tris, pH 7.6, and 0.2 mM PMSF). Lysates were cleared by centrifugation at 13,000 g for 30 min and supernatants were stored at -20~ After preclearing of lysates with protein A-Sepharose (75 #1 of a 1:1 buffer/Sepharose slurry), the addition of 2 #1 of ascitic fluid for 45 rain, and the addition of 50 #1 of protein A-Sepharose for 30 rain, resulted in quantitative precipitation of the respective antigen. To assure quantitative retrieval of immune complexes, the lysates were incubated two more times with protein A-Sepharose before adding the next mAb. The Sepharose beads were washed twice with the first washing buffer (0.2% NP-40, 10 mM Tris-HC1, pH 7.6, 140 mM NaCI, 2 mM EDTA) followed by two additional washing steps with the second (0.2% NP-40, 10 mM Tris-HC1, pH 7.6, 500 mM NaC1, 2 mM EDTA) and third washing buffer (10 mM Tris-HC1, pH 7.6). Immune complexes were eluted by incubation with sample buffer and analyzed by 10 (37, 38, 40) . The two HpaI sites flanking the ie2 promoter (arrow) were used to excise this regulatory element and to replace it by a 3.5-kb fragment consisting of the iel promoter upstream of the bacterial/acZ gene open reading frame coding for/~-gal. The resulting plasmid was then used to isolate the MCMV lacl recombinant generated by homologous recombination after cotransfection of cells with linear DNA of the modified HindlII fragment and MCMV strain Smith DNA.
Results

Lack of Selectivity in the Inhibition of Antigen Presentation by MCMV E Gene Products.
During the E phase of MCMV replication, the presentation of the IE1 antigen pp89 by the M H C class I molecule L a is prevented. We reasoned that if pp89 was the only target of inhibition, then intrinsic properties of pp89 should account for the lack of presentation.
Other If ACt D is not added immediately after removing CH but at later times (see Fig. 2 A, bottom) , the synthesized IE proteins activate the transcription of E genes. The duration of E gene transcription is defined by the time at which Act D is added. Translation of E mRNA leads to the synthesis of E proteins. With this protocol, conditions of limited E gene expression after enhanced IE gene expression are achieved. Note that conditions permissive for E gene expression (IE + E conditions depicted in Fig. 2 A) , were associated with inhibited presentation of not only pp89 as described before (28), but also of B-gal, and, with comparable kinetics, presentation was eventually abolished (Fig. 2, B, right) .
In the case of pp89, protein synthesis continues during MCMV E gene expression. When the rate of 3-gal and pp89 synthesis was analyzed in cells infected with MCMV lacl, the decreasing rate of synthesis was found comparable between both proteins under IE and under E conditions (Fig.  2 C) . A comparison between cell lines producing significantly different amounts of pp89 had revealed that quantitative differences do not account for the inhibition of antigen presentation (28). Because two completely unrelated antigens are subjected to the same inhibition of antigen presentation after expression as MCMV IE genes, we reasoned that a common step in the MHC class I processing and presentation pathway is affected by MCMV E gene functions.
Correct Processing of pp89 in Absence of Antigen Presentation.
The MHC class I processing and presentation pathway can be subdivided into: (a) proteolytic processing, (b) peptide transport into the ER, (c) complex formation of MHC class I heavy chain, ~/2m and peptide, and (d) transport of the trimolecular complex to the cell surface. Proteolytic processing and peptide transport were not amenable to testing. Therefore, the latter steps were analyzed. H-2 a cells infected with the vaccinia recombinant MCMV-ieI-VAC express pp89, and the naturally processed nonapeptide 16SyPHFMFTNL 176 is found in cell lysates after acid extraction (31) . It coelutes with the synthetic nonamer as a single peak in fraction number 25 of our standard reverse-phase HPLC runs. The biological activity of extracted peptides is demonstrated in a standard CTL assay, where pp89-specilic CTL lyse H-2 d cells that were incubated with the relevant duted peptide fraction. Cells infected with MCMV under IE conditions contained biological activity in the expected nonapeptide peak at fraction 25 and, in addition, also in fraction 23 (Fig. 3 A, top) (Del Val et al., manuscript in preparation) . No biological activity could be recovered from uninfected cells (data not shown). Remarkably, when natural peptides were retrieved from E phase-infected cells that did not present the antigen, essentiaUy the same dution profile of biological activity was observed ( Fig. 3 A, bottom) . Thus, there are no qualitative changes in the natural peptide composition of infected cells that could account for the differences in antigen presentation.
In addition, the serial dilution of the fractions representing the two antigenic peaks revealed no quantitative differences between cells that did or did not present antigen regarding the content of endogenously processed peptide (Fig. 3 B, top and bottom, respectively). Thus, accurate processing of pp89 did not result in peptide presentation at the cell surface. We concluded that MCMV E gene products interfere with antigen presentation at a step later than processing.
Naturally Processed Peptides Are Bound to the MHC Class I Heavy Chain L ~. Current evidence indicates that only
peptides bound by MHC class I molecules are protected from complete degradation (41) . Accordingly, peptides can be retrieved only from cells that express the presenting MHC class I molecule(s). The conclusion, however, that the processed peptides of pp89 were already transported into the ER and associated with L d was premature, because, at least after exogenous addition to cells, the nonapeptide can effectively bind also to the MHC class I molecule K a (42). Thus, it was conceivable that during the E phase most of the processed peptides were in fact bound by K a and not by L d, and therefore not available for CTL from BALB/c mice, which do not generate Ka-restricted pp89-specific CTL (28). According to this explanation the biological activity of naturally processed peptides from E phase-infected cells would become only apparent, because extracted peptides, liberated from the assumed binding to K a, could now be bound by the L d molecules of the target cells after external addition.
To settle this point, peptides were acid extracted from MCMV-infected cells of the H-2 a"a mouse strain. This strain differs from BALB/c in that it lacks the gene encoding L a (43) . As shown in Fig. 4 , no peptides with biological activity detectable by pp89-specific CTL could be releaved from H-2 amz cells expressing IE genes of MCMV, and there was also no activity extractable from H-2 d"a ceils at the E phase of infection (not shown). It was therefore concluded that the detection of pp89-derived peptide activity reflects quantitative peptide binding to L a, even after E gene expression.
Correct Assembly of MHC Class I Complexes. Peptides play two cooperative roles during the assembly of MHC dass I molecules, the folding of the heavy chain that can occur in absence of ~2m, and the stabilization of preformed complexes of heavy chain and ~2m (13, 14) . The isolation of peptide from cells that express E genes indicated correct processing, transport into the ER, and association with L a heavy chains, but not necessarily the formation of the stable trimolectdar complex. The MHC class I molecule L d is known for its reduced affinity for B2m and its ddayed transit to the cell surface, where it is expressed at a lower density (44) . In addition, many L a heavy chains remain in a conformation typical for the lack of B2m association, suggesting a critical susceptibility of L d heavy chains during protein folding (18).
Therefore, the amount and conformational properties of synthesized L a molecules were compared after metabolic labding of MCMV-infected cells representing both experimental conditions (Fig. 5, top) . Quantitative immunoprecipitations were performed sequentially, starting with the mAb 64-3-7, which detects only L a heavy chains in a conformation that is not associated with ~2m (18). This antibody precipitated "~90% of the L a molecules. No quantitative differences associated with the different phases of MCMV gene expression were observed (data not shown). After clearing of the cell lysates from excess antibody, L d molecules were precipitated with the c~3 domain-specific mAb 28-14-8s, which detects the remaining fl2m-complexed L d molecules, and separated by SDS-PAGE (Fig. 5, left) . L d molecules migrated with a relative electrophoretic mobility of 46 kD as a broad band that probably included differently glycosylated forms. Despite the fact that 64-3-7 + L a molecules were removed in the first precipitation step, the amount of precipitated 32m was still low, perhaps due to the instability of the La/B2m complex during the precipitation procedure. Note, however, that Ld/fl2m complexes were found in comparable amounts under both infection conditions. Considering the L d dependence of peptide isolation, we thus concluded that correct trimolecular class I complexes are also formed in cells that are unable to present the antigen.
In view of the particular properties of L d, the MHC class I molecule D d was also studied, which represents a MHC dass I molecule that quantitatively and firmly associates with 32m, and matures faster. Again, the amount of D d complexes remained constant after transition of MCMV infection into the E phase (Fig. 5, right) . Remarkably, and different from L d, the D a molecules synthesized at different times of MCMV gene expression exhibited a different electrophoretic mobility. Under mock and IE conditions, several bands were found, probably reflecting stages of maturation to forms of complex glycosylation. Transition to the E phase, however, restricted this pattern to a major band of fast mobility, probably representing the glycoprotein precursor. The coprecipitation of 32m indicated that intracellular assembly of the MHC class I complex was not affected. The fact that not only antigen presentation by L d but also the glycosylation of D d was affected suggested a general effect of MCMV E gene products on MHC class I heavy chain maturation.
Defective Glycosylation of MHC Class I Complexes. To locate the effect on the posttranslational modification, the susceptibility of MHC class I molecules to Endo H digestion was determined. As it is the case for other glycoproteins, MHC class I molecules cotranslationally acquire a high-mannose core of N-linked digosaccharides in the ER. Endo H preferentially cleaves immature N-linked oligosaccharides characteristic of glycoproteins that have not reached the medial-Golgi compartment (45) . Further processing of the oligosaccharide chain by enzymes located in the medial-Golgi compartment leads to the fully mature glycoproteins and renders the glycan structure resistant to Endo H digestion (46) .
Maturation of MHC dass I molecules was studied by pulsechase experiments. A long pulse of 90 min was required to follow the fate of newly synthesized L d molecules because the expression of L d in embryonic fibroblasts is very low (see also Fig. 7, top left) . In mock-infected cells and also in IEinfected cells (Fig. 6, top/eft) , the L d heavy chains, in agreement with a previous report (44), slowly matured to Endo H-resistant forms. This was apparent from comparing the relative amount of Endo H-susceptible and -resistant forms after the pulse at different time points of the chase period. Even after a chase period of 270 min, some L a heavy chains remained Endo H susceptible. The decrease in the overall content of L d molecules at that time reflects the instability of this molecule and explains the poor surface expression of L a. The comparison between L d molecules from cells representing both infection conditions revealed a clear difference in the acquisition of Endo H resistance. In contrast to the IEinfected ceils, the majority of molecules synthesized during the E phase (Fig. 6, top right) remained in the Endo H-sensitive form throughout the chase period, which indicated that they had not gained access to the Golgi enzymes. Note, however, that in spite of defective maturation, there was no difference in the overall stability of L d molecules.
Essentially the same result was obtained for D d heavy chains. Although this molecule is already completely processed during the 90-min pulse to Endo H-resistant forms under mock and IE gene expression conditions (Fig. 6 , bottom/eft), E gene expression prevented glycoprotein maturation with an efficiency comparable with L d without affecting protein stability (Fig. 7, bottom right) . Similar results were also obtained for K a (data not shown). It has been reported that full glycosylation is not a prerequisite for MHC class I molecule transport and cell surface expression (47) . Thus, we concluded that after expression of MCMV E genes, the correctly assembled MHC class I complexes remain Endo H sensitive, first hours of the E phase (28), and complex formation between an MHC class I molecule and an MCMV E protein could be compatible with transport to the cell surface. The surface density of the MHC class I molecules L a and D a was determined by cytofluorometric analysis at a later stage of the E phase, 18 h postinfection, in order to reveal the fate of nascent MHC class I molecules. The E phase arrest was achieved by infection of cells with MCMV in the presence of phosphonoacetic acid, which blocks viral DNA replication and the subsequent expression of late-phase genes. A decrease of L a and D a molecules to almost undetectable levels was observed, impressive in particular for D d, which is more abundantly expressed (Fig. 7, compare A and/3) . Similar results were obtained also for the H-2 proteins K a, Lq, K b, D b, K k, and D k (data not shown). In contrast, other glycoproteins, like CD71 (transferrin receptor) and the adhesion molecule CD44 (pgp-1), essentially remained unaffected by infection (Fig. 7, C and D) . Under the premise that CD44 and CD71 have a turnover rate comparable to that of MHC class I molecules, these data would imply that MHC class I glycoproteins represent a preferential target for the MCMV E gene effect. We concluded that after expression of MCMV E genes the correctly assembled MHC class I complexes do not reach the medial-Golgi compartment and remain Endo H sensitive.
Discussion
We demonstrate that the mechanism of interference by MCMV E gene products with antigen presentation to CTL (28) can be described as a block in the intracellular transport of MHC class I complexes through the Golgi compartment. The dramatic inhibitory effect of MCMV E gene products on viral antigen presentation provides a paradigm for the potential of a herpes virus to interfere with the recognition of infected cells by CTL. CMV persists for life in the infected host, and CD8 § T lymphocyte function is the hallmark of host control of CMV (reviewed in reference 27). For a virus that is under control of the cellular immune response, the interference with MHC class I molecule transport is clearly the most effective evasion mechanism that can be envisaged. Provided that the glycosylation studies correctly define the location at which the Golgi transport of MHC class I molecules is blocked, the results imply that binding of peptides to MHC class I molecules occurs in the ER/c/s-Golgi compartment, and not in subsequent compartments along the secretory pathway.
When the cascade of MCMV gene expression is restricted to IE genes, MCMV-specific CTL detect processed peptides that are derived from the MCMV IE protein pp89 and presented by the MHC class I molecule L d. Subsequent expression of E genes for a short time prevents pp89 presentation. Yet, E gene expression has little effect on pp89 synthesis, the surface expression of MHC class I molecules appears unchanged when antigen presentation is prevented, and infected cells are still recognized by CTL that detect a viral E antigen that we could not define in molecular terms. This suggested a selective effect on pp89 antigen processing (28).
In the light of the new evidence provided in this paper, however, the mechanism of inhibition is much more general than previously thought.
We report on the following findings. (a) Antigen selectivity was excluded by insertion of the bacterial gene lacZ coding for the enzyme B-gal into the MCMV genome under control of the iel promoter. Although both proteins, pp89 and/3-gal, differ with regard to primary sequence, intracellular distribution, and function, presentation of both antigens was blocked by MCMV E gene expression. (b) Naturally processed peptides extracted from cells that synthesized pp89 in presence or absence of E proteins had the same biochemical properties, and the same amount of biochemical activity was retrieved in both cases. Therefore, antigen processing was correct in nonpresenting cells, and peptide competition could not explain the failure of antigen presentation. (c) The L ddependent presence of peptides in nonpresenting cells revealed peptide transport into the ER and peptide association with the heavy chain, and studies on the conformational properties of the heavy chain provided evidence for correct formation of the trimolecular complex. (d) The observation that during the E phase of viral infection the nascent heavy chains did not acquire resistance to Endo H digestion and did not reach the cell surface revealed a block in the normal maturation and transport of MHC class I molecules. This transport block affects selectively MHC class I molecules.
The fact that we failed to see the general effect on MHC class I molecule maturation in the earlier communication (28) is easily explained. We investigated the effect on L d at the time it became apparent. Thus, we determined only the resident population of surface-expressed L a molecules that appeared normal, whereas the fate of nascent molecules was not controlled. The thoroughness of the antigen presentation blockade, however, may be due to characteristic features of the L a surface molecules. It is expressed on the cell surface at levels three to four times lower than K d and D d, the association with B2m is delayed, and the slower maturation is documented by a delayed processing of the N-linked oligosaccharide (44) . L a molecules that are not occupied by peptide ligands appear at the cell surface, and external addition of peptides to cells can alter the conformation and enhance surface expression (17, 18). Data of Cliristinck et al. (49) demonstrate that as few as 200 MHC class I-peptide complexes suf~ce for recognition by CTL in vitro. Therefore, if the transport blockade were incomplete, the number of exported complexes might not fall below the detection threshold for other Ld-presented antigens or for other peptide-MHC class I molecule complexes. By such a mechanism we now explain the escape of an MCMV E antigen from the regulatory effect (28). We have observed that a 10ofold difference in the amount of naturally processed and La-presented peptides can be decisive for target formation in vitro and for recovery from lethal viral infection in vivo (31) .
A transport block of nascent MHC class I molecules to the cell surface, either by treatment with brefeldin A (10, 11) , or by the action of the adenovirus protein E3/19K, prevents presentation of endogenous antigens. Reversal of the brefeldin A treatment and removal of the ER/c/s-Golgi retention signal of E3/19K (26), respectively, restores presentation. In the antigen presentation-deficient cell mutant T2, an ER translocation signal rescues presentation of an endogenous peptide (50) . Indirect evidence derived from in vitro systems suggests that MHC dass I molecules bind synthetic peptides in the same compartment where they bind to B2m (12) (13) (14) . These data demonstrate that nascent MHC class I molecules are required for peptide presentation, but do not define the place of peptide charging because naturally processed peptides have not been isolated under conditions of inhibited MHC class I molecule transport. If the lack of Endo H resistance correctly defines the location of the transport block by MCMV, then MHC class I molecules residing in the ER/cisGolgi compartment already contain the processed peptides.
Viral effects on MHC expression and on other cell membrane proteins relevant for immunosurveiUance have been discussed for a number of viruses. Yet, with the exception of the adenoviruses, there has been no precise molecular analysis (for listing, see reference 20). The adenoviruses provide the example that viruses belonging to the same family can use related, but different strategies, such as an effect on MHC dass I mRNA processing (21, 22) or on the intraceUular transport of MHC class I molecules (23-25).
For the understanding of CMV infection and disease, it has been a matter of debate whether, in addition to profiting from host conditions of defective cellular immune control, the virus itself has evolved strategies to evade immunosurveillance even in the immunocompetent host. Grundy et al. (51) reported that human CMV (HCMV) binds exogenous ~2m, perhaps masking the virus against the detection by antibodies, Remarkably, HCMV contains an open reading flame (UL18) encoding a glycoprotein with sequence similarity to MHC class I molecules (52) . Upon expression by a recombinant vaccinia virus, the UL18 gene product can complex with 32m (53) . The latter authors observed that in HCMVinfected cells no synthesis of mature HLA class I molecules occurred despite unchanged mRNA levels. Although expression of the UL18 gene product has not yet been detected in HCMV-infected cells, this led them to speculate that a function of the HLA homologue could be to sequester 32m, making it unavailable to nascent cellular class I heavy chains. Sequestration of Bzm would result in a block of peptide presentation by MHC class I molecules and predict an escape from cellular immune control. In MCMV the mechanisms are clearly different. We did not see an inhibition of MHC class I molecule assembly, and only at a later stage was the maturation of the trimolecular complex inhibited. In this context it is worth mentioning that it was recently observed in HCMV-infected cells that HLA dass I molecules were synthesized but remained retained intracellularly (J. E. Grundy, personal communication).
Why is the full glycosylation of assembled ternary complex impaired subsequent to the expression of MCMV E genes? A retention signal is contained within the six COOHterminal amino acids of the E3/19K protein of adenovirus 2 (56) and mediates the EK/c/s-Golgi retention of complexes between E3/19K and MHC dass I molecules (23) reflected by the Endo H sensitivity of MHC molecules (24, 25). Although representing an attractive speculation, the inhibitory MCMV protein must not necessarily represent a functional homologue of the E3/19K protein. Unlike in adenovirus, no complex formation could be detected under comparable experimental conditions (24) between an MCMV E protein and the nascent MHC molecules. The other possibility, that MCMV E gene products interact with glycosyl transferases, was considered unlikely because other glycoproteins reach the surface and are correctly glycosylated (H. Hengel, unpublished data). The rate-limiting step of glycoprotein transport appears to be the acquisition of the correct tertiary and quarternary structure, and improperly folded molecules and proteins in intermediate stages of folding are retained in the ER or in c/s-Golgi compartment (57) (58) (59) . Particularly, unassembled MHC dass I molecules are retained in a recycling pathway between the ER and c/s-Golgi compartment (60) . With the available antibodies we have not detected any effect of MCMV on the assembly of the ternary complex. Degen and Williams (61) recently described an 88-kD protein that participates in the biogenesis of MHC class I molecules. This protein binds to the heavy chains and dissociates when the assembled heavy chain-fl2m complex reaches the medialGolgi compartment and acquires resistance to Endo H digestion. It is worth studying whether the 88-kD protein is still bound to this complex, because its dissociation should not be triggered by peptide binding but by some other, later event.
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